查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372823

獸醫現場診斷市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、動物類型（伴侶動物和牲畜動物）、樣本類型、測試類別、最終用戶、地區和競爭細分

Veterinary Point of Care Diagnostics Market-Global Industry Size, Share, Trends, Opportunity, & Forecast, 2018-2028 Segmented By Product, Animal Type (Companion & Livestock Animals), Sample Type, Testing Category, End User, Region & Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年獸醫照護端診斷市場價值為 15.1 億美元，預計在預測期內將大幅成長，預計到 2028 年年複合成長率 (CAGR) 為 10.11%。

在多種因素的共同推動下，該市場目前正呈現顯著成長。全球寵物飼養量的增加，加上人們對寵物健康意識的增強，導致對快速、便利的診斷解決方案的需求激增。技術進步已經產生了複雜的、方便用戶使用的設備，可以提供快速、準確的結果，滿足獸醫和寵物主人的喜好。

包括糖尿病和傳染病在內的各種獸醫疾病的流行強調了及時、準確診斷的重要性，最終改善了動物醫療保健結果。監管支援以及獸醫診所和醫院的擴張進一步增強了市場的成長潛力。此外，診斷設備製造商、獸醫機構和學術機構之間的夥伴關係和協作也有助於該領域的持續創新。

市場概況
預測期 2024-2028
2022 年市場規模 15.1億美元
2028 年市場規模 26.7億美元
2023-2028 年年複合成長率 10.11%
成長最快的細分市場 傳染性疾病
最大的市場 北美洲

隨著成本效益、遠距醫療和遠端監控日益受到重視，現場護理診斷在實現即時健康評估方面發揮關鍵作用。隨著競爭推動創新，獸醫現場診斷市場已做好持續成長的準備，成為更廣泛的獸醫醫療保健產業的重要組成部分。

主要市場促進因素

增加寵物擁有量

寵物飼養的成長趨勢是獸醫現場診斷市場快速成長的重要動力。全球範圍內寵物擁有量的激增，受到多種因素的影響，從多個方面促進了市場的擴張。

獸醫疾病的流行

獸醫疾病的流行在影響獸醫現場診斷市場的成長方面發揮著至關重要的作用。這項因素對診斷工具的需求產生重大影響，並推動獸醫診斷領域的創新。

首先，各種獸醫疾病（包括動物傳染病、慢性病和癌症）日益流行，需要定期監測和及時診斷。隨著這些疾病變得越來越常見，獸醫和寵物主人都在尋求準確、快速的診斷解決方案，以便在早期階段檢測和管理這些疾病。照護端診斷具有及時檢測的優勢，可以更快地進行治療干涉，並有可能改善受影響動物的預後。

此外，新的和不斷發展的疾病以及可能影響動物和人類的人畜共患疾病的出現強調了有效和高效診斷的重要性。能夠快速識別這些疾病的即時檢測對於防止其傳播並確保動物及其人類照護人員的健康和安全至關重要。當疾病爆發或監測具有公共衛生影響的疾病時，對此類診斷的需求變得特別明顯。

此外，寵物慢性疾病（如糖尿病和腎臟疾病）盛行率不斷上升，需要定期監測和管理。照護端診斷為寵物主人提供了一種在家中監測動物健康狀況的便捷方式，從而減少了頻繁去獸醫診所的需要。這不僅提高了寵物的生活品質，也推動了對攜帶式診斷設備的需求。

此外，隨著全球寵物貿易的不斷擴大，疾病傳播的風險以及旅行動物健康證明的需求變得越來越重要。現場診斷是在國際旅行或貿易之前驗證動物健康狀況的重要工具，使其成為促進動物全球流動不可或缺的工具。

主要市場挑戰

成本障礙

獸醫現場診斷市場面臨的主要挑戰之一是成本障礙問題。雖然即時診斷設備在便利性和快速結果方面具有眾多優勢，但其開發、製造和維護成本可能帶來重大挑戰。

製造現場診斷設備通常需要使用先進技術和專用材料，導致生產成本更高。此外，確保這些設備的準確性和可靠性需要嚴格的品質控制流程，這可能會進一步增加製造費用。對於財力有限的小型獸醫診所和診所來說，這些成本可能特別沉重，可能會限制他們採用和使用這些先進診斷工具的能力。

維護成本對於照護端診斷的整體承受能力也起著至關重要的作用。為了保持這些設備的最佳運作狀態，需要定期校準、維修和更新。維護費用會隨著時間的推移而累積，並可能阻礙獸醫診所投資於即時護理技術，特別是如果他們缺乏支持持續維護的預算或基礎設施。

成本障礙的挑戰也延伸到了寵物主人。一些即時診斷測試可能需要專門的耗材或試劑，這可能很昂貴。如果寵物主人承擔這些費用，定期檢測的負擔能力可能會成為一個問題，可能會限制診斷頻率並影響寵物的整體健康管理。

診斷準確度

確保獸醫現場護理診斷的準確性是一項嚴峻的挑戰。雖然這些設備具有快速獲得結果和現場測試的優勢，但保持一致的高準確度可能很複雜。樣品品質變化、操作員錯誤和設備校準等因素會影響結果的可靠性。

主要問題之一是可能出現假陽性或假陰性，這可能對患者護理產生重大影響。誤診可能會導致不必要的治療、增加醫療費用以及對寵物主人造成過度的壓力。相反，未能發現疾病或狀況可能會延遲必要的干涉措施，可能導致動物的健康狀況惡化。

此外，照護端診斷設備可能並不總是提供與實驗室測試相同水平的準確性，而實驗室測試通常被認為是黃金標準。這可能會對結果的信心造成挑戰，並且可能需要通過額外的測試進行確認，這可能既耗時又昂貴。

主要市場趨勢

遠距醫療和遠端監控的興起

遠距醫療和遠端監控的興起是重塑獸醫現場診斷格局的重要趨勢。通訊技術的進步以及獸醫和寵物主人不斷變化的偏好加速了這一趨勢。

獸醫護理中的遠距醫療涉及獸醫和寵物主人透過視訊通話或訊息平台進行遠端諮詢。另一方面，遠端監控使獸醫能夠追蹤動物的健康狀況並從穿戴式裝置和家用診斷套件接收即時資料。照護端診斷在實現遠端監控方面發揮關鍵作用，因為它們使寵物主人能夠收集並與獸醫共享重要的健康資料，而無需經常親自拜訪。

這種趨勢有幾個優點。首先，它提高了獸醫護理的可及性，特別是在偏遠地區或緊急情況下，當立即進入獸醫診所可能具有挑戰性時。它還可以減輕動物在就診時可能感到焦慮的壓力。

此外，COVID-19 大流行進一步加速了遠距醫療和遠端監控在獸醫護理中的採用，因為它需要採取物理疏遠措施。這場危機凸顯了照護端診斷在遠端提供基本健康資料、確保護理連續性、同時最大限度地減少人際接觸方面的潛力。

照護端診斷與遠距醫療和遠端監控平台的整合可以即時評估動物的健康狀況，促進早期疾病檢測和及時干涉。它使寵物主人能夠積極參與寵物的醫療保健，並為獸醫提供更全面的動物健康狀況視圖。

人工智慧與數據分析的整合

人工智慧 (AI) 和資料分析的整合是獸醫現場診斷市場的變革趨勢。它代表了診斷設備功能及其為獸醫和寵物主人提供可行見解的能力的飛躍。

人工智慧驅動的演算法被用來快速分析即時診斷測試所產生的複雜資料。這項技術可以識別對人類解釋可能具有挑戰性的微妙模式和趨勢。例如，在基於影像的診斷中，人工智慧可以檢測放射線影像中的異常情況或高度準確地識別顯微玻片中的特定細胞。

數據分析與人工智慧結合，可以開發預測模型。這些模型可以根據歷史資料、遺傳因素和診斷測試的即時輸入來預測健康問題。這樣可以採取早期干涉和預防措施，顯著提高動物照護品質。

人工智慧和資料分析在獸醫診斷中的一項突出應用是血液檢測結果的解釋。演算法可以快速分析全面的血液檢測，考慮器官功能、電解質平衡和血球計數等多個參數。這可以對動物的健康狀況進行更精確和全面的評估。

此外，人工智慧驅動的診斷設備可以適應並從與患者和醫療保健提供者的互動中學習，隨著時間的推移不斷提高其診斷準確性。他們可以提供考慮個別動物特定需求的診斷建議，從而有助於獸醫護理中的個人化醫療。

細分市場洞察

產品洞察

消耗品、試劑和套件在獸醫照護端診斷市場中佔據主導地位，預計在未來幾年將繼續擴大。這些組件是診斷設備操作不可或缺的一部分，其重要性在於其消耗品性質和經常性需求。首先，消耗品、試劑和試劑盒對於在獸醫實踐中進行各種診斷測試至關重要。無論是血液檢測、尿液分析或分子診斷，這些成分都是與樣本相互作用產生結果的核心要素。獸醫專業人員每天依靠這些消耗品來做出有關動物健康的明智決定。其次，消耗品的重複性推動了持續的需求。獸醫診所和實驗室需要穩定的試劑和試劑盒供應，以滿足患者的診斷需求。因此，消耗品佔獸醫機構持續營運支出的很大一部分，確保了製造商和供應商的可靠市場。

第三，診斷技術的進步通常涉及新的和改進的消耗品、試劑和試劑盒的開發。製造商不斷創新，以提高這些組件的準確性、特異性和易用性，從而透過產品開發推動市場成長。

此外，遠端和行動獸醫服務中採用現場診斷增加了對攜帶式、方便的套件和耗材的需求，這些套件和耗材可以輕鬆運輸並在不同環境中使用。

區域洞察

到2022年，北美地區已成為獸醫現場診斷市場的領導者。首先，北美擁有強大且發達的獸醫醫療保健基礎設施。該地區擁有大量獸醫診所、醫院和研究機構，處於採用先進診斷技術的最前線。這個廣泛的醫療保健提供者網路為 VPOC 診斷設備和相關耗材創造了強大的需求基礎。其次，該地區高度重視寵物飼養和動物健康。尤其是美國和加拿大，多年來寵物擁有量大幅增加，導致人們對寵物醫療保健需求的認知不斷提高。北美的寵物主人更傾向於投資尖端診斷工具和服務，為 VPOC 市場的成長做出貢獻。此外，北美是獸醫領域的創新和研究中心。 VPOC 市場的領先公司以及學術機構正在積極致力於研發工作，以創建先進的診斷解決方案。這種創新文化推動了新技術的快速採用並推動了市場成長。此外，北美有利的監管框架和嚴格的品質標準激發了人們對 VPOC 診斷產品的信心。這些法規確保了診斷設備的安全性、準確性和可靠性，培養了獸醫專業人員和寵物主人之間的信任。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球獸醫照護端診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（消耗品、試劑和套件與儀器和設備）
    • 依動物類型{伴侶動物（狗、貓、馬、其他）、牲畜（牛、豬、家禽、其他）
    • 依樣本類型（血液/血漿/血清、尿液、糞便、其他）
    • 依適應症（傳染病、一般疾病、其他）
    • 按測試類別（血液學、診斷影像學、細菌學、病毒學、細胞學、臨床化學、寄生蟲學、血清學、其他）
    • 按最終使用者（獸醫醫院和診所、家庭護理機構、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美獸醫照護端診斷市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依動物類型
    • 依樣品類型
    • 按指示
    • 按測試類別
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲獸醫照護端診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依動物類型
    • 依樣品類型
    • 按指示
    • 按測試類別
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區獸醫現場診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依動物類型
    • 依樣品類型
    • 按指示
    • 按測試類別
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲獸醫照護端診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依動物類型
    • 依樣品類型
    • 按指示
    • 按測試類別
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲獸醫照護端診斷市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依動物類型
    • 依樣品類型
    • 按指示
    • 按測試類別
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非獸醫照護端診斷
    • 沙烏地阿拉伯獸醫照護端診斷
    • 阿拉伯聯合大公國獸醫照護端診斷

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購

第 13 章：全球獸醫照護端診斷市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代治療類型的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Zoetis Inc.
    • IDEXX Laboratories, Inc.
    • Virbac SA
    • Heska Corporation
    • Thermo Fisher Scientific, Inc
    • Mindray Medical International Limited
    • Esaote SPA
    • FUJIFILM Corporation
    • Woodley Equipment Company Ltd

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 16301

The Veterinary Point of Care Diagnostics Market, valued at USD 1.51 Billion in 2022, is expected to undergo substantial growth in the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 10.11% through 2028.

This market is currently witnessing remarkable growth, driven by a convergence of various factors. The global rise in pet ownership, combined with an increased awareness of pet health, has led to a surge in demand for rapid and convenient diagnostic solutions. Technological advancements have yielded sophisticated, user-friendly devices that provide quick and accurate results, catering to the preferences of both veterinarians and pet owners.

The prevalence of various veterinary diseases, including diabetes and infectious ailments, emphasizes the importance of timely and precise diagnoses, ultimately improving animal healthcare outcomes. Regulatory support and the expansion of veterinary clinics and hospitals further reinforce the market's growth potential. Additionally, partnerships and collaborations among diagnostic device manufacturers, veterinary facilities, and academic institutions contribute to ongoing innovation in this sector.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.51 Billion
Market Size 2028USD 2.67 Billion
CAGR 2023-202810.11%
Fastest Growing SegmentInfectious Diseases
Largest MarketNorth America

As cost-efficiency, telemedicine, and remote monitoring gain prominence, point-of-care diagnostics assume a pivotal role in enabling real-time health assessments. With competition driving innovation, the veterinary point-of-care diagnostics market is well-positioned for sustained growth, establishing itself as a crucial component of the broader veterinary healthcare industry.

Key Market Drivers

Increasing Pet Ownership

The increasing trend of pet ownership is a significant driving force behind the rapid growth of the veterinary point-of-care diagnostics market. This surge in pet ownership is seen across the globe and is influenced by various factors, contributing to the expansion of the market in several ways.

Firstly, the growing number of pet owners translates into a larger patient base for veterinarians. As more people open their homes to companion animals, the demand for veterinary services, including diagnostics, naturally rises. This trend is not limited to traditional pets like dogs and cats but extends to exotic pets as well, widening the market's scope.

Secondly, pet owners are increasingly viewing their pets as cherished family members, leading to a heightened awareness of the importance of maintaining their health and well-being. As a result, pet owners are more willing to invest in veterinary care, including diagnostic tests, to ensure their pets lead healthy lives. This mindset shift has created a substantial demand for point-of-care diagnostics that offer quick and accurate results, allowing for timely interventions and personalized treatment plans.

Thirdly, the emotional attachment between pet owners and their animals has led to a willingness to go the extra mile for their pets' healthcare needs. This includes regular check-ups and preventive measures, often involving point-of-care diagnostics for early disease detection. Pet owners are now more proactive in seeking out healthcare services for their pets, driving up the demand for veterinary diagnostic tools.

Additionally, the rise in pet ownership has led to an increased need for diagnostics in various settings beyond traditional veterinary clinics. Pet owners are seeking diagnostic tools that they can use at home to monitor their pets' health, especially for chronic conditions like diabetes. This has spurred innovation in the development of user-friendly, portable, and accurate point-of-care diagnostic devices that cater to both veterinary professionals and pet owners.

Prevalence of Veterinary Diseases

The prevalence of veterinary diseases plays a vital role in influencing the growth of the veterinary point-of-care diagnostics market. This factor has a significant impact on the demand for diagnostic tools and drives innovation in the field of veterinary diagnostics.

First and foremost, the increasing prevalence of various veterinary diseases, including infectious diseases, chronic conditions, and cancer among animals, necessitates regular monitoring and prompt diagnosis. As these diseases become more common, veterinarians and pet owners alike seek accurate and rapid diagnostic solutions to detect and manage these conditions at an early stage. Point-of-care diagnostics offer the advantage of timely detection, enabling quicker treatment interventions and potentially improving the prognosis for affected animals.

Moreover, the emergence of new and evolving diseases, as well as zoonotic diseases that can affect both animals and humans, underscores the importance of effective and efficient diagnostics. Point-of-care tests that can quickly identify these diseases are critical for preventing their spread and ensuring the health and safety of both animals and their human caregivers. The need for such diagnostics becomes particularly evident in cases of disease outbreaks or when monitoring diseases with public health implications.

Additionally, the rising prevalence of chronic diseases in pets, such as diabetes and kidney disease, necessitates regular monitoring and management. Point-of-care diagnostics provide a convenient way for pet owners to monitor their animals' health at home, reducing the need for frequent visits to veterinary clinics. This not only improves the quality of life for pets but also drives demand for portable diagnostic devices.

Furthermore, as the global pet trade continues to expand, the risk of disease transmission and the need for health certificates for traveling animals have become increasingly important. Point-of-care diagnostics are essential tools in verifying the health status of animals before international travel or trade, making them indispensable in facilitating global movements of animals.

Key Market Challenges

Cost Barriers

One of the key challenges facing the veterinary point-of-care diagnostics market is the issue of cost barriers. While point-of-care diagnostic devices offer numerous advantages in terms of convenience and rapid results, their development, manufacturing, and maintenance costs can pose significant challenges.

Manufacturing point-of-care diagnostic devices often involves the use of advanced technology and specialized materials, contributing to higher production costs. Additionally, ensuring the accuracy and reliability of these devices requires rigorous quality control processes, which can further increase manufacturing expenses. These costs can be especially burdensome for smaller veterinary practices and clinics with limited financial resources, potentially limiting their ability to adopt and use these advanced diagnostic tools.

Maintenance costs also play a crucial role in the overall affordability of point-of-care diagnostics. Regular calibration, servicing, and updates are necessary to keep these devices functioning optimally. Maintenance expenses can accumulate over time and may deter veterinary practices from investing in point-of-care technology, especially if they lack the budget or infrastructure to support ongoing maintenance.

The cost barrier challenge extends to pet owners as well. Some point-of-care diagnostic tests may require specialized consumables or reagents, which can be expensive. In cases where pet owners are responsible for these costs, the affordability of regular testing may become a concern, potentially limiting the frequency of diagnostics and affecting the overall health management of their pets.

Diagnostic Accuracy

Ensuring the accuracy of point-of-care diagnostics in veterinary medicine is a critical challenge. While these devices offer the advantage of rapid results and on-site testing, maintaining consistently high levels of accuracy can be complex. Factors such as variations in sample quality, operator error, and device calibration can influence the reliability of results.

One of the primary concerns is the potential for false positives or false negatives, which can have significant consequences for patient care. Misdiagnoses can lead to unnecessary treatments, increased healthcare costs, and undue stress for pet owners. Conversely, failing to detect a disease or condition can delay necessary interventions, potentially leading to worsened health outcomes for animals.

Additionally, point-of-care diagnostic devices may not always provide the same level of accuracy as laboratory-based tests, which are often considered the gold standard. This can create challenges in terms of confidence in the results and may necessitate confirmation through additional testing, which can be time-consuming and costly.

Key Market Trends

Rise in Telemedicine and Remote Monitoring

The rise of telemedicine and remote monitoring is a significant trend reshaping the landscape of veterinary point-of-care diagnostics. This trend has been accelerated by advancements in communication technology and the changing preferences of both veterinarians and pet owners.

Telemedicine in veterinary care involves the remote consultation between veterinarians and pet owners through video calls or messaging platforms. Remote monitoring, on the other hand, enables veterinarians to track an animal's health status and receive real-time data from wearable devices and at-home diagnostic kits. Point-of-care diagnostics play a pivotal role in enabling remote monitoring, as they empower pet owners to collect and share vital health data with veterinarians without the need for frequent in-person visits.

This trend offers several advantages. First, it enhances accessibility to veterinary care, particularly in remote areas or during emergencies when immediate access to a veterinary clinic may be challenging. It also reduces stress for animals that may be anxious during visits to a clinic.

Furthermore, the COVID-19 pandemic further accelerated the adoption of telemedicine and remote monitoring in veterinary care as it necessitated physical distancing measures. This crisis highlighted the potential of point-of-care diagnostics to provide essential health data remotely, ensuring continuity of care while minimizing human contact.

The integration of point-of-care diagnostics with telemedicine and remote monitoring platforms allows for real-time assessment of an animal's health, facilitating early disease detection and timely interventions. It empowers pet owners to actively participate in their pets' healthcare and provides veterinarians with a more comprehensive view of an animal's health over time.

Integration of AI and Data Analytics

The integration of artificial intelligence (AI) and data analytics is a transformative trend in the veterinary point-of-care diagnostics market. It represents a leap forward in the capabilities of diagnostic devices and their ability to provide actionable insights for veterinarians and pet owners.

AI-driven algorithms are being employed to analyze complex data generated by point-of-care diagnostic tests rapidly. This technology can identify subtle patterns and trends that may be challenging for human interpretation. For example, in image-based diagnostics, AI can detect abnormalities in radiographic images or identify specific cells in microscopic slides with a high degree of accuracy.

Data analytics, coupled with AI, enables the development of predictive models. These models can anticipate health issues based on historical data, genetic factors, and real-time inputs from diagnostic tests. This allows for early intervention and preventive measures, significantly improving the quality of care for animals.

One prominent application of AI and data analytics in veterinary diagnostics is in the interpretation of blood test results. Algorithms can quickly analyze comprehensive blood panels, considering multiple parameters such as organ function, electrolyte balance, and blood cell counts. This results in more precise and holistic assessments of an animal's health status.

Moreover, AI-driven diagnostic devices can adapt and learn from their interactions with patients and healthcare providers, continuously improving their diagnostic accuracy over time. They can provide diagnostic recommendations that consider the specific needs of an individual animal, thereby contributing to personalized medicine in veterinary care.

Segmental Insights

Product Insights

The Consumables, Reagents, & Kits dominate the Veterinary Point of Care Diagnostics market and is predicted to continue expanding over the coming years. These components are integral to the operation of diagnostic devices, and their significance lies in their consumable nature and recurring need. Firstly, consumables, reagents, and kits are essential for performing a wide range of diagnostic tests in veterinary practice. Whether it's blood tests, urine analysis, or molecular diagnostics, these components serve as the core elements that interact with samples to produce results. Veterinary professionals rely on these consumables daily to make informed decisions about animal health. Secondly, the recurring nature of consumables drives consistent demand. Veterinary clinics and laboratories require a steady supply of reagents and kits to meet the diagnostic needs of their patients. As a result, consumables form a substantial portion of the ongoing operational expenses for veterinary facilities, ensuring a reliable market for manufacturers and suppliers.

Thirdly, advancements in diagnostic technologies often involve the development of new and improved consumables, reagents, and kits. Manufacturers are continually innovating to enhance the accuracy, specificity, and ease of use of these components, thereby driving market growth through product development.

Moreover, the adoption of point-of-care diagnostics in remote and mobile veterinary services has boosted the demand for portable and convenient kits and consumables that can be easily transported and used in diverse settings.

Regional Insights

The North America region has established itself as the leader in the Veterinary Point of Care Diagnostics Market in 2022. Firstly, North America boasts a robust and well-developed veterinary healthcare infrastructure. The region is home to a large number of veterinary clinics, hospitals, and research institutions that are at the forefront of adopting advanced diagnostic technologies. This extensive network of healthcare providers creates a strong demand base for VPOC diagnostic devices and associated consumables. Secondly, the region places a high premium on pet ownership and animal health. The United States and Canada, in particular, have witnessed a substantial increase in pet ownership over the years, resulting in heightened awareness of pet healthcare needs. Pet owners in North America are more inclined to invest in cutting-edge diagnostic tools and services, contributing to the growth of the VPOC market. Additionally, North America is a hub of innovation and research in the field of veterinary medicine. Leading companies in the VPOC market, as well as academic institutions, are actively engaged in research and development efforts to create advanced diagnostic solutions. This innovation culture drives the rapid adoption of new technologies and fuels market growth. Furthermore, favorable regulatory frameworks and stringent quality standards in North America inspire confidence in VPOC diagnostic products. These regulations ensure the safety, accuracy, and reliability of diagnostic devices, fostering trust among veterinary professionals and pet owners.

Key Market Players

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Virbac SA
  • Heska Corporation
  • Thermo Fisher Scientific, Inc
  • Mindray Medical International Limited
  • Esaote S.P.A.
  • FUJIFILM Corporation
  • Woodley Equipment Company Ltd

Report Scope:

In this report, the Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Point of Care Diagnostics Market, Product:

  • Short PIVCs
  • Huber Needles
  • Midline Catheters
  • PICCs
  • CVCs
  • Dialysis Catheters
  • Implantable Ports

Veterinary Point of Care Diagnostics Market, Animal Type:

  • Companion Animals
  • Livestock Animals

Veterinary Point of Care Diagnostics Market, Sample Type:

  • Blood/Plasma/Serum
  • Urine
  • Fecal
  • Others

Veterinary Point of Care Diagnostics Market, Indication:

  • Infectious Disease
  • General Ailments
  • Others

Veterinary Point of Care Diagnostics Market, Testing Category:

  • Hematology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Parasitology
  • Serology
  • Others

Veterinary Point of Care Diagnostics Market, End User:

  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Others

Veterinary Point of Care Diagnostics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Veterinary Point of Care Diagnostics Market.

Available Customizations:

  • Veterinary Point of Care Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Point of Care Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Reagents, & Kits v/s Instruments & Devices)
    • 5.2.2. By Animal Type {Companion Animals (Dogs, Cats, Horses, Others), Livestock Animals (Cattle, Swine, Poultry, Others)
    • 5.2.3. By Sample Type (Blood/Plasma/Serum, Urine, Fecal, Others)
    • 5.2.4. By Indication (Infectious Disease, General Ailments, Others)
    • 5.2.5. By Testing Category (Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology, Others)
    • 5.2.6. By End User (Veterinary Hospitals & Clinics, Home Care Settings, Others)
    • 5.2.7. By Region
    • 5.2.8. By Company (2022)
  • 5.3. Market Map

6. North America Veterinary Point of Care Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Animal Type
    • 6.2.3. By Sample Type
    • 6.2.4. By Indication
    • 6.2.5. By Testing Category
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Point of Care Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Animal Type
        • 6.3.1.2.3. By Sample Type
        • 6.3.1.2.4. By Indication
        • 6.3.1.2.5. By Testing Category
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Veterinary Point of Care Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Animal Type
        • 6.3.2.2.3. By Sample Type
        • 6.3.2.2.4. By Indication
        • 6.3.2.2.5. By Testing Category
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Veterinary Point of Care Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Animal Type
        • 6.3.3.2.3. By Sample Type
        • 6.3.3.2.4. By Indication
        • 6.3.3.2.5. By Testing Category
        • 6.3.3.2.6. By End User

7. Europe Veterinary Point of Care Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Animal Type
    • 7.2.3. By Sample Type
    • 7.2.4. By Indication
    • 7.2.5. By Testing Category
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Sample Type
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By Testing Category
        • 7.3.1.2.6. By End User
    • 7.3.2. United Kingdom Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Sample Type
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By Testing Category
        • 7.3.2.2.6. By End User
    • 7.3.3. Italy Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Sample Type
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By Testing Category
        • 7.3.3.2.6. By End User
    • 7.3.4. France Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Animal Type
        • 7.3.4.2.3. By Sample Type
        • 7.3.4.2.4. By Indication
        • 7.3.4.2.5. By Testing Category
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Veterinary Point of Care Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Animal Type
        • 7.3.5.2.3. By Sample Type
        • 7.3.5.2.4. By Indication
        • 7.3.5.2.5. By Testing Category
        • 7.3.5.2.6. By End User

8. Asia-Pacific Veterinary Point of Care Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Animal Type
    • 8.2.3. By Sample Type
    • 8.2.4. By Indication
    • 8.2.5. By Testing Category
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Sample Type
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By Testing Category
        • 8.3.1.2.6. By End User
    • 8.3.2. India Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Sample Type
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By Testing Category
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Sample Type
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By Testing Category
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By Sample Type
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By Testing Category
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Veterinary Point of Care Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By Sample Type
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By Testing Category
        • 8.3.5.2.6. By End User

9. South America Veterinary Point of Care Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Animal Type
    • 9.2.3. By Sample Type
    • 9.2.4. By Indication
    • 9.2.5. By Testing Category
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Point of Care Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Sample Type
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By Testing Category
        • 9.3.1.2.6. By End User
    • 9.3.2. Argentina Veterinary Point of Care Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Sample Type
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By Testing Category
        • 9.3.2.2.6. By End User
    • 9.3.3. Colombia Veterinary Point of Care Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Sample Type
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By Testing Category
        • 9.3.3.2.6. By End User

10. Middle East and Africa Veterinary Point of Care Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Animal Type
    • 10.2.3. By Sample Type
    • 10.2.4. By Indication
    • 10.2.5. By Testing Category
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Point of Care Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Sample Type
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By Testing Category
        • 10.3.1.2.6. By End User
    • 10.3.2. Saudi Arabia Veterinary Point of Care Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Sample Type
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By Testing Category
        • 10.3.2.2.6. By End User
    • 10.3.3. UAE Veterinary Point of Care Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Sample Type
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By Testing Category
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions

13. Global Veterinary Point of Care Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Zoetis Inc.
    • 15.5.2. IDEXX Laboratories, Inc.
    • 15.5.3. Virbac SA
    • 15.5.4. Heska Corporation
    • 15.5.5. Thermo Fisher Scientific, Inc
    • 15.5.6. Mindray Medical International Limited
    • 15.5.7. Esaote S.P.A.
    • 15.5.8. FUJIFILM Corporation
    • 15.5.9. Woodley Equipment Company Ltd

16. Strategic Recommendations

17. About Us & Disclaimer